新余国科(300722) - 2020 Q1 - 季度财报

Financial Performance - Total revenue for Q1 2020 was ¥22,926,062.05, a decrease of 44.74% compared to ¥41,490,849.01 in the same period last year[9] - Net profit attributable to shareholders was ¥67,286.81, down 98.86% from ¥5,879,882.51 year-on-year[9] - Net profit excluding non-recurring gains and losses was -¥98,800.71, a decline of 102.04% compared to ¥4,834,719.14 in the previous year[9] - Basic earnings per share decreased to ¥0.0006, down 98.86% from ¥0.0525 year-on-year[9] - The company's operating revenue for the first quarter was 22,926,062.05 yuan, a decrease of 44.74% compared to the same period last year, primarily due to the impact of the COVID-19 pandemic on production and logistics[20] - The net profit attributable to shareholders was 67,286.81 yuan, down 98.86% year-on-year, while the net profit excluding non-recurring gains and losses was -98,800.71 yuan, a decline of 102.04%[20] - Total operating revenue for Q1 2020 was ¥22,926,062.05, a decrease of 44.7% compared to ¥41,490,849.01 in Q1 2019[44] - Net profit for Q1 2020 was ¥189,244.94, a significant decline of 96.8% from ¥5,897,935.02 in Q1 2019[46] Cash Flow and Assets - Operating cash flow for the period was -¥15,946,563.31, an improvement of 42.09% from -¥27,537,708.39 in the same period last year[9] - Cash and cash equivalents at the end of the period amounted to 48,878,114.71 yuan, representing a 58.57% increase compared to the previous year, mainly due to improved cash flow from operating activities[19] - The company reported a net cash outflow from operating activities of -15,946,563.31 yuan, which was an improvement of 42.09% compared to the previous year[19] - The company's cash and cash equivalents decreased to CNY 48,878,114.71 from CNY 125,553,508.44, reflecting a decline of approximately 61.1%[36] - The total cash inflow from operating activities increased from 26,624,996.35 to 27,297,485.75, reflecting a growth of approximately 2.5%[57] - The total cash outflow from investing activities was ¥60,728,830.42, compared to ¥84,421,003.35 in the previous period, indicating reduced investment spending[55] Assets and Liabilities - Total assets at the end of the reporting period were ¥513,723,250.77, a decrease of 2.21% from ¥525,329,100.14 at the end of the previous year[9] - The company's total assets as of March 31, 2020, were ¥519,399,901.56, down from ¥530,025,405.21 at the end of 2019[42] - Current assets decreased to ¥209,497,593.41 from ¥217,404,484.42, reflecting a decline of 3.9%[41] - Total liabilities decreased to ¥82,273,898.60 from ¥93,862,513.03, a reduction of 12.5%[42] - The company’s total liabilities decreased from 93,862,513.03 to 76,334,873.19, indicating a reduction of about 18.8%[64] Shareholder Information - The company reported a total of 9,097 common shareholders at the end of the reporting period[13] - The largest shareholder, Jiangxi Military Industry Control Group, holds 36.83% of the shares, totaling 41,253,334 shares[13] - Net assets attributable to shareholders increased slightly by 0.14% to ¥448,719,060.39 from ¥448,078,135.53 at the end of the previous year[9] - The company's equity attributable to shareholders increased slightly to ¥448,719,060.39 from ¥448,078,135.53[41] Government Support and Donations - Government subsidies recognized in the current period amounted to ¥342,278.54[10] - The company made a donation of 400,000 yuan to support COVID-19 relief efforts during the reporting period[18] Risks and Challenges - The company faces risks from the ongoing COVID-19 pandemic, which could impact production and supply chain stability, and is taking measures to enhance pandemic prevention efforts[22] - The company has not experienced any safety production accidents during the reporting period, but acknowledges inherent risks associated with its products[24] Research and Development - Research and development expenses for Q1 2020 were ¥4,014,247.80, an increase of 8.3% compared to ¥3,707,790.67 in Q1 2019[45] - The company is focusing on developing new technologies and products to create new economic growth points in the future[28] Fund Management - The total amount of raised funds is 14,647.81 million CNY, with 404.19 million CNY invested in the current quarter[27] - Cumulative amount of raised funds used is 8,120.13 million CNY, with 16.71% of the total raised funds having their purposes changed[27] - The cumulative amount of changed purposes for raised funds is 2,447.66 million CNY[27] - The company has temporarily used CNY 57,500,000.00 of idle raised funds for cash management, with a balance remaining as of the end of the reporting period[36] - The company approved the use of up to CNY 12,000,000.00 of idle raised funds for cash management, effective for one year from the shareholders' meeting[36] Operational Insights - The top five suppliers accounted for 64.19% of total purchases, with a total procurement amount of 9,006,439.04 yuan, indicating a slight change in supplier dynamics[21] - The top five customers contributed 37.85% of total revenue, with sales amounting to 8,676,868.67 yuan, reflecting a shift in customer orders due to the pandemic[21] - The company did not report any new product launches or significant market expansion strategies during this quarter[49] Compliance and Audits - The company did not conduct an audit for the first quarter report, which may affect the reliability of the financial data presented[65]